切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - eIF4F - cysteine protease - Inward Rectifier Potassium (Kir) Channels - Protease-Activated Receptors

11件产品中的 1-10

页面
每页
清除全部
  1. Z-FA-FMK
    A8170 Z-FA-FMK
    Target: cysteine protease
    Summary: 半胱氨酸蛋白酶抑制剂
      ≥13.45 mg/mL
      insoluble in H2O
  2. 4E1RCat
    B3697 4E1RCat
    Target: eIF4F
    Summary: eIF4E:eIF4G与eIF4E:4E-BP1相互作用的双重抑制剂
      ≥23.85 mg/mL
      insoluble in H2O
  3. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  4. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  5. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  6. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  7. Vorapaxar
    A8809 Vorapaxar
    中文名: 沃拉帕沙
    Target: Protease-Activated Receptors
    Summary: PAR-1拮抗剂
      ≥24.65 mg/mL
      insoluble in H2O
  8. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  9. ML161
    A8229 ML161
    Target: Protease-Activated Receptors
    Summary: PAR1抑制剂
      ≥16.4 mg/mL
      insoluble in H2O
  10. E-64-c
    A8162 E-64-c
    中文名: 阿洛司他丁酸
    Target: cysteine protease
    Summary: 半胱氨酸蛋白酶抑制剂
      ≥31.4 mg/mL
      insoluble in H2O

11件产品中的 1-10

页面
每页